What is Evestra?
Evestra, Inc. is a privately held biopharmaceutical firm headquartered in Texas, dedicated to enhancing global women's health and advancing oncology treatments. The company's robust product pipeline encompasses pre-clinical and clinical-stage assets targeting critical areas such as fertility control, endometriosis, hormone replacement therapy, and overactive bladder. With a foundation built on over a decade of industry experience, Evestra leverages next-generation healthcare technologies to address significant unmet medical needs, aiming to improve the overall health and well-being of women worldwide.
How much funding has Evestra raised?
Evestra has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Evestra?
The substantial capital infusion, particularly the recent strategic investment, positions Evestra for accelerated growth and the advancement of its key product candidates through late-stage clinical trials and potential market entry. This funding will likely be allocated towards expanding research and development capabilities, scaling manufacturing operations, and strengthening its commercialization strategy. Evestra's focus on women's health and oncology remains a key differentiator, suggesting a strategic direction aimed at capturing significant market share in these specialized therapeutic areas. The company's trajectory indicates a strong commitment to innovation and addressing patient needs.
See full Evestra company page
